| Suramin is a medication used to treat African sleeping sickness and river blindness. It is the treatment of choice for sleeping sickness without central nervous system involvement. It is given by injection into a vein.
Suramin causes a fair number of side effects. Common side effects include nausea, vomiting, diarrhea, headache, skin tingling, and weakness. Sore palms of the hands and soles of the feet, trouble seeing, fever, and abdominal pain may also occur. Severe side effects may include low blood pressure, decreased level of consciousness, kidney problems, and low blood cell levels. It is unclear if it is safe when breastfeeding.
Suramin was made at least as early as 1916. It is on the World Health Organization's List of Essential Medicines. In the United States it can be acquired from the Centers for Disease Control (CDC). In regions of the world where the disease is common suramin is provided for free by the World Health Organization (WHO). |
|
Read full article at Wikipedia
|
InChI=1S/C21H30O2/c1- 5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1 |
| CYQFCXCEBYINGO-IAGOWNOFSA-N |
| [H][C@@]12CCC(C)=C[C@@]1([H])c1c(O)cc(CCCCC)cc1OC2(C)C |
|
|
Cannabis sativa
(NCBI:txid3483)
|
Found in
aerial part
(BTO:0001658).
Acetone extract of Dried, powdered and heated flowered aerial parts
See:
PubMed
|
|
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via phytocannabinoid )
non-narcotic analgesic
A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
cannabinoid receptor agonist
An agonist that binds to and activates cannabinoid receptors.
(via cannabinoid )
|
|
|
non-narcotic analgesic
A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
hallucinogen
Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations and other alterations of mood and thinking.
|
|
View more via ChEBI Ontology
|
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
|
|
(-)-delta9-trans-Tetrahydrocannabinol
|
ChemIDplus
|
|
1-trans-delta-9-Tetrahydrocannabinol
|
ChemIDplus
|
|
3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol
|
ChemIDplus
|
|
6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
|
NIST Chemistry WebBook
|
|
Δ1-tetrahydrocannabinol
|
SUBMITTER
|
|
delta9-Tetrahydrocannabinol
|
KEGG COMPOUND
|
|
Δ9-tetrahydrocannabinol
|
UniProt
|
|
Δ9-THC
|
SUBMITTER
|
|
Dronabinol
|
KEGG COMPOUND
|
Dronabinolum
|
ChemIDplus
|
|
Tetrahydrocannabinol
|
KEGG COMPOUND
|
|
1972-08-3
|
CAS Registry Number
|
KEGG COMPOUND
|
|
1972-08-3
|
CAS Registry Number
|
NIST Chemistry WebBook
|
|
1972-08-3
|
CAS Registry Number
|
ChemIDplus
|
|
4354308
|
Reaxys Registry Number
|
Reaxys
|
|
